Device
Auto-Injector (AI)
Auto-Injector (AI) is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Study of Injections of LY3074828 in Healthy Participants
NCT03886948
completedphase_1
A Study of Two Formulations of LY3074828 in Healthy Participants
NCT03662100
completedphase_1
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
NCT04004988
completedphase_1
A Study of Different Injectable Formulations of LY3375880 in Healthy Participants
NCT03913260
completedphase_1
A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)
NCT02996019
Clinical Trials (5)
Showing 5 of 5 trials
NCT03886948Phase 1
A Study of Injections of LY3074828 in Healthy Participants
NCT03662100Phase 1
A Study of Two Formulations of LY3074828 in Healthy Participants
NCT04004988Phase 1
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
NCT03913260Phase 1
A Study of Different Injectable Formulations of LY3375880 in Healthy Participants
NCT02996019Phase 1
A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5